Concepedia

The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study

Jenny Leung, Andrew Ho, Tai‐Pang Ip, Gavin Lee, Annie W.C. Kung

Bone · 2005 · 32 citations · 32 references

DOI

Concepts

References

32

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

, , +17

Hip fractures in the elderly: A world-wide projection

Cyrus Cooper, G. Campion, L. Joseph Melton · Osteoporosis International · 1992 · 3.2K citations

, , +12

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Steven T. Harris · JAMA · 1999 · 2.5K citations

, , +16

Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>

S. R. Cummings · JAMA · 1998 · 2.3K citations

, , +16

Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. <i>JAMA</i> 2002; 288(3): 321-333

Dr Ailsa Gebbie · Journal of Family Planning and Reproductive Health Care · 2002 · 1.2K citations · Full text

, , +11